nodes	percent_of_prediction	percent_of_DWPC	metapath
Famotidine—Glossodynia—Sorafenib—liver cancer	0.0476	0.0484	CcSEcCtD
Famotidine—Interstitial pneumonia—Sorafenib—liver cancer	0.0329	0.0334	CcSEcCtD
Famotidine—Interstitial lung disease—Sorafenib—liver cancer	0.0225	0.0228	CcSEcCtD
Famotidine—Rhabdomyolysis—Sorafenib—liver cancer	0.018	0.0183	CcSEcCtD
Famotidine—Supraventricular extrasystoles—Epirubicin—liver cancer	0.0158	0.016	CcSEcCtD
Famotidine—Influenza like illness—Sorafenib—liver cancer	0.0154	0.0157	CcSEcCtD
Famotidine—Supraventricular extrasystoles—Doxorubicin—liver cancer	0.0146	0.0148	CcSEcCtD
Famotidine—Gynaecomastia—Sorafenib—liver cancer	0.0142	0.0145	CcSEcCtD
Famotidine—Pain in extremity—Sorafenib—liver cancer	0.0115	0.0117	CcSEcCtD
Famotidine—Dry skin—Sorafenib—liver cancer	0.0106	0.0108	CcSEcCtD
Famotidine—Toxic epidermal necrolysis—Sorafenib—liver cancer	0.0104	0.0106	CcSEcCtD
Famotidine—Aspartate aminotransferase increased—Sorafenib—liver cancer	0.0104	0.0106	CcSEcCtD
Famotidine—Abdominal discomfort—Sorafenib—liver cancer	0.00956	0.00972	CcSEcCtD
Famotidine—Neutropenia—Sorafenib—liver cancer	0.00933	0.00948	CcSEcCtD
Famotidine—Erectile dysfunction—Sorafenib—liver cancer	0.00919	0.00934	CcSEcCtD
Famotidine—Stevens-Johnson syndrome—Sorafenib—liver cancer	0.00882	0.00896	CcSEcCtD
Famotidine—Bone marrow depression—Epirubicin—liver cancer	0.0087	0.00885	CcSEcCtD
Famotidine—Jaundice—Sorafenib—liver cancer	0.00867	0.00881	CcSEcCtD
Famotidine—Bone marrow depression—Doxorubicin—liver cancer	0.00805	0.00819	CcSEcCtD
Famotidine—Erythema multiforme—Sorafenib—liver cancer	0.00755	0.00767	CcSEcCtD
Famotidine—Gingivitis—Epirubicin—liver cancer	0.00749	0.00761	CcSEcCtD
Famotidine—Tinnitus—Sorafenib—liver cancer	0.00744	0.00757	CcSEcCtD
Famotidine—Flushing—Sorafenib—liver cancer	0.00741	0.00753	CcSEcCtD
Famotidine—Arrhythmia—Sorafenib—liver cancer	0.00713	0.00725	CcSEcCtD
Famotidine—Alopecia—Sorafenib—liver cancer	0.00706	0.00717	CcSEcCtD
Famotidine—Mental disorder—Sorafenib—liver cancer	0.007	0.00711	CcSEcCtD
Famotidine—Gingivitis—Doxorubicin—liver cancer	0.00693	0.00704	CcSEcCtD
Famotidine—Dysgeusia—Sorafenib—liver cancer	0.00681	0.00692	CcSEcCtD
Famotidine—Extravasation—Epirubicin—liver cancer	0.00674	0.00685	CcSEcCtD
Famotidine—Jaundice cholestatic—Epirubicin—liver cancer	0.00669	0.0068	CcSEcCtD
Famotidine—Muscle spasms—Sorafenib—liver cancer	0.00668	0.00679	CcSEcCtD
Famotidine—Ventricular extrasystoles—Epirubicin—liver cancer	0.00651	0.00661	CcSEcCtD
Famotidine—Viral infection—Epirubicin—liver cancer	0.00651	0.00661	CcSEcCtD
Famotidine—Anaemia—Sorafenib—liver cancer	0.00642	0.00653	CcSEcCtD
Famotidine—Angioedema—Sorafenib—liver cancer	0.00635	0.00646	CcSEcCtD
Famotidine—Syncope—Sorafenib—liver cancer	0.00623	0.00634	CcSEcCtD
Famotidine—Extravasation—Doxorubicin—liver cancer	0.00623	0.00633	CcSEcCtD
Famotidine—Leukopenia—Sorafenib—liver cancer	0.00622	0.00632	CcSEcCtD
Famotidine—Jaundice cholestatic—Doxorubicin—liver cancer	0.00619	0.00629	CcSEcCtD
Famotidine—Loss of consciousness—Sorafenib—liver cancer	0.00611	0.00621	CcSEcCtD
Famotidine—Cough—Sorafenib—liver cancer	0.00607	0.00616	CcSEcCtD
Famotidine—Atrioventricular block—Epirubicin—liver cancer	0.00606	0.00616	CcSEcCtD
Famotidine—Viral infection—Doxorubicin—liver cancer	0.00602	0.00612	CcSEcCtD
Famotidine—Ventricular extrasystoles—Doxorubicin—liver cancer	0.00602	0.00612	CcSEcCtD
Famotidine—Neck pain—Epirubicin—liver cancer	0.00595	0.00605	CcSEcCtD
Famotidine—Musculoskeletal pain—Epirubicin—liver cancer	0.00595	0.00605	CcSEcCtD
Famotidine—Arthralgia—Sorafenib—liver cancer	0.00592	0.00601	CcSEcCtD
Famotidine—Myalgia—Sorafenib—liver cancer	0.00592	0.00601	CcSEcCtD
Famotidine—Dry mouth—Sorafenib—liver cancer	0.00579	0.00588	CcSEcCtD
Famotidine—Influenza like illness—Epirubicin—liver cancer	0.00571	0.0058	CcSEcCtD
Famotidine—Anaphylactic shock—Sorafenib—liver cancer	0.00567	0.00577	CcSEcCtD
Famotidine—Infection—Sorafenib—liver cancer	0.00564	0.00573	CcSEcCtD
Famotidine—Atrioventricular block—Doxorubicin—liver cancer	0.00561	0.0057	CcSEcCtD
Famotidine—Shock—Sorafenib—liver cancer	0.00558	0.00567	CcSEcCtD
Famotidine—Thrombocytopenia—Sorafenib—liver cancer	0.00555	0.00565	CcSEcCtD
Famotidine—Neck pain—Doxorubicin—liver cancer	0.0055	0.00559	CcSEcCtD
Famotidine—Musculoskeletal pain—Doxorubicin—liver cancer	0.0055	0.00559	CcSEcCtD
Famotidine—Anorexia—Sorafenib—liver cancer	0.00541	0.0055	CcSEcCtD
Famotidine—Influenza like illness—Doxorubicin—liver cancer	0.00528	0.00537	CcSEcCtD
Famotidine—Musculoskeletal discomfort—Sorafenib—liver cancer	0.00517	0.00525	CcSEcCtD
Famotidine—Dyspepsia—Sorafenib—liver cancer	0.00499	0.00508	CcSEcCtD
Famotidine—Decreased appetite—Sorafenib—liver cancer	0.00493	0.00501	CcSEcCtD
Famotidine—Fatigue—Sorafenib—liver cancer	0.00489	0.00497	CcSEcCtD
Famotidine—Photosensitivity—Epirubicin—liver cancer	0.00486	0.00494	CcSEcCtD
Famotidine—Constipation—Sorafenib—liver cancer	0.00485	0.00493	CcSEcCtD
Famotidine—Pain—Sorafenib—liver cancer	0.00485	0.00493	CcSEcCtD
Famotidine—Gastrointestinal pain—Sorafenib—liver cancer	0.00464	0.00471	CcSEcCtD
Famotidine—Urticaria—Sorafenib—liver cancer	0.00451	0.00458	CcSEcCtD
Famotidine—Photosensitivity—Doxorubicin—liver cancer	0.00449	0.00457	CcSEcCtD
Famotidine—Abdominal pain—Sorafenib—liver cancer	0.00448	0.00456	CcSEcCtD
Famotidine—Body temperature increased—Sorafenib—liver cancer	0.00448	0.00456	CcSEcCtD
Famotidine—Pain in extremity—Epirubicin—liver cancer	0.00427	0.00434	CcSEcCtD
Famotidine—Migraine—Epirubicin—liver cancer	0.0042	0.00427	CcSEcCtD
Famotidine—Hypersensitivity—Sorafenib—liver cancer	0.00418	0.00425	CcSEcCtD
Famotidine—Face oedema—Epirubicin—liver cancer	0.00412	0.00419	CcSEcCtD
Famotidine—Asthenia—Sorafenib—liver cancer	0.00407	0.00414	CcSEcCtD
Famotidine—Pruritus—Sorafenib—liver cancer	0.00401	0.00408	CcSEcCtD
Famotidine—Pain in extremity—Doxorubicin—liver cancer	0.00395	0.00401	CcSEcCtD
Famotidine—Dry skin—Epirubicin—liver cancer	0.00391	0.00397	CcSEcCtD
Famotidine—Migraine—Doxorubicin—liver cancer	0.00388	0.00395	CcSEcCtD
Famotidine—Diarrhoea—Sorafenib—liver cancer	0.00388	0.00395	CcSEcCtD
Famotidine—Toxic epidermal necrolysis—Epirubicin—liver cancer	0.00384	0.0039	CcSEcCtD
Famotidine—Aspartate aminotransferase increased—Epirubicin—liver cancer	0.00384	0.0039	CcSEcCtD
Famotidine—Face oedema—Doxorubicin—liver cancer	0.00381	0.00387	CcSEcCtD
Famotidine—Dizziness—Sorafenib—liver cancer	0.00375	0.00381	CcSEcCtD
Famotidine—Influenza—Epirubicin—liver cancer	0.00369	0.00375	CcSEcCtD
Famotidine—Dry skin—Doxorubicin—liver cancer	0.00362	0.00368	CcSEcCtD
Famotidine—Vomiting—Sorafenib—liver cancer	0.00361	0.00367	CcSEcCtD
Famotidine—Rash—Sorafenib—liver cancer	0.00358	0.00364	CcSEcCtD
Famotidine—Dermatitis—Sorafenib—liver cancer	0.00357	0.00363	CcSEcCtD
Famotidine—Toxic epidermal necrolysis—Doxorubicin—liver cancer	0.00355	0.00361	CcSEcCtD
Famotidine—Aspartate aminotransferase increased—Doxorubicin—liver cancer	0.00355	0.00361	CcSEcCtD
Famotidine—Headache—Sorafenib—liver cancer	0.00355	0.00361	CcSEcCtD
Famotidine—Bronchitis—Epirubicin—liver cancer	0.00355	0.0036	CcSEcCtD
Famotidine—Pancytopenia—Epirubicin—liver cancer	0.0035	0.00356	CcSEcCtD
Famotidine—Dysuria—Epirubicin—liver cancer	0.00345	0.0035	CcSEcCtD
Famotidine—Neutropenia—Epirubicin—liver cancer	0.00345	0.0035	CcSEcCtD
Famotidine—Upper respiratory tract infection—Epirubicin—liver cancer	0.00343	0.00348	CcSEcCtD
Famotidine—Influenza—Doxorubicin—liver cancer	0.00341	0.00347	CcSEcCtD
Famotidine—Pollakiuria—Epirubicin—liver cancer	0.00341	0.00346	CcSEcCtD
Famotidine—Nausea—Sorafenib—liver cancer	0.00337	0.00342	CcSEcCtD
Famotidine—Photosensitivity reaction—Epirubicin—liver cancer	0.00337	0.00342	CcSEcCtD
Famotidine—Bronchitis—Doxorubicin—liver cancer	0.00328	0.00333	CcSEcCtD
Famotidine—Stevens-Johnson syndrome—Epirubicin—liver cancer	0.00326	0.00331	CcSEcCtD
Famotidine—Pancytopenia—Doxorubicin—liver cancer	0.00324	0.00329	CcSEcCtD
Famotidine—Jaundice—Epirubicin—liver cancer	0.0032	0.00326	CcSEcCtD
Famotidine—Dysuria—Doxorubicin—liver cancer	0.00319	0.00324	CcSEcCtD
Famotidine—Neutropenia—Doxorubicin—liver cancer	0.00319	0.00324	CcSEcCtD
Famotidine—Upper respiratory tract infection—Doxorubicin—liver cancer	0.00317	0.00322	CcSEcCtD
Famotidine—Pollakiuria—Doxorubicin—liver cancer	0.00315	0.0032	CcSEcCtD
Famotidine—Haematuria—Epirubicin—liver cancer	0.00313	0.00319	CcSEcCtD
Famotidine—Photosensitivity reaction—Doxorubicin—liver cancer	0.00311	0.00316	CcSEcCtD
Famotidine—Sinusitis—Epirubicin—liver cancer	0.00308	0.00313	CcSEcCtD
Famotidine—Agranulocytosis—Epirubicin—liver cancer	0.00307	0.00312	CcSEcCtD
Famotidine—Stevens-Johnson syndrome—Doxorubicin—liver cancer	0.00302	0.00306	CcSEcCtD
Famotidine—Bradycardia—Epirubicin—liver cancer	0.003	0.00305	CcSEcCtD
Famotidine—Jaundice—Doxorubicin—liver cancer	0.00296	0.00301	CcSEcCtD
Famotidine—Hepatitis—Epirubicin—liver cancer	0.00295	0.003	CcSEcCtD
Famotidine—Pharyngitis—Epirubicin—liver cancer	0.00293	0.00298	CcSEcCtD
Famotidine—Haematuria—Doxorubicin—liver cancer	0.0029	0.00295	CcSEcCtD
Famotidine—Sinusitis—Doxorubicin—liver cancer	0.00285	0.0029	CcSEcCtD
Famotidine—Agranulocytosis—Doxorubicin—liver cancer	0.00284	0.00288	CcSEcCtD
Famotidine—Erythema multiforme—Epirubicin—liver cancer	0.00279	0.00284	CcSEcCtD
Famotidine—Bradycardia—Doxorubicin—liver cancer	0.00278	0.00283	CcSEcCtD
Famotidine—Tinnitus—Epirubicin—liver cancer	0.00275	0.0028	CcSEcCtD
Famotidine—Flushing—Epirubicin—liver cancer	0.00274	0.00278	CcSEcCtD
Famotidine—Hepatitis—Doxorubicin—liver cancer	0.00273	0.00278	CcSEcCtD
Famotidine—Pharyngitis—Doxorubicin—liver cancer	0.00271	0.00275	CcSEcCtD
Famotidine—Arrhythmia—Epirubicin—liver cancer	0.00264	0.00268	CcSEcCtD
Famotidine—Alopecia—Epirubicin—liver cancer	0.00261	0.00265	CcSEcCtD
Famotidine—Mental disorder—Epirubicin—liver cancer	0.00259	0.00263	CcSEcCtD
Famotidine—Erythema multiforme—Doxorubicin—liver cancer	0.00258	0.00262	CcSEcCtD
Famotidine—Tinnitus—Doxorubicin—liver cancer	0.00255	0.00259	CcSEcCtD
Famotidine—Flushing—Doxorubicin—liver cancer	0.00253	0.00258	CcSEcCtD
Famotidine—Dysgeusia—Epirubicin—liver cancer	0.00252	0.00256	CcSEcCtD
Famotidine—Back pain—Epirubicin—liver cancer	0.00248	0.00253	CcSEcCtD
Famotidine—Muscle spasms—Epirubicin—liver cancer	0.00247	0.00251	CcSEcCtD
Famotidine—Arrhythmia—Doxorubicin—liver cancer	0.00244	0.00248	CcSEcCtD
Famotidine—Alopecia—Doxorubicin—liver cancer	0.00241	0.00245	CcSEcCtD
Famotidine—Mental disorder—Doxorubicin—liver cancer	0.00239	0.00243	CcSEcCtD
Famotidine—Anaemia—Epirubicin—liver cancer	0.00237	0.00241	CcSEcCtD
Famotidine—Agitation—Epirubicin—liver cancer	0.00236	0.0024	CcSEcCtD
Famotidine—Dysgeusia—Doxorubicin—liver cancer	0.00233	0.00237	CcSEcCtD
Famotidine—Syncope—Epirubicin—liver cancer	0.0023	0.00234	CcSEcCtD
Famotidine—Leukopenia—Epirubicin—liver cancer	0.0023	0.00234	CcSEcCtD
Famotidine—Back pain—Doxorubicin—liver cancer	0.0023	0.00234	CcSEcCtD
Famotidine—Muscle spasms—Doxorubicin—liver cancer	0.00229	0.00232	CcSEcCtD
Famotidine—Palpitations—Epirubicin—liver cancer	0.00227	0.00231	CcSEcCtD
Famotidine—Loss of consciousness—Epirubicin—liver cancer	0.00226	0.00229	CcSEcCtD
Famotidine—Cough—Epirubicin—liver cancer	0.00224	0.00228	CcSEcCtD
Famotidine—Convulsion—Epirubicin—liver cancer	0.00223	0.00226	CcSEcCtD
Famotidine—Anaemia—Doxorubicin—liver cancer	0.0022	0.00223	CcSEcCtD
Famotidine—Arthralgia—Epirubicin—liver cancer	0.00219	0.00222	CcSEcCtD
Famotidine—Chest pain—Epirubicin—liver cancer	0.00219	0.00222	CcSEcCtD
Famotidine—Myalgia—Epirubicin—liver cancer	0.00219	0.00222	CcSEcCtD
Famotidine—Agitation—Doxorubicin—liver cancer	0.00218	0.00222	CcSEcCtD
Famotidine—Anxiety—Epirubicin—liver cancer	0.00218	0.00222	CcSEcCtD
Famotidine—Dry mouth—Epirubicin—liver cancer	0.00214	0.00217	CcSEcCtD
Famotidine—Syncope—Doxorubicin—liver cancer	0.00213	0.00217	CcSEcCtD
Famotidine—Leukopenia—Doxorubicin—liver cancer	0.00213	0.00216	CcSEcCtD
Famotidine—Confusional state—Epirubicin—liver cancer	0.00211	0.00215	CcSEcCtD
Famotidine—Palpitations—Doxorubicin—liver cancer	0.0021	0.00213	CcSEcCtD
Famotidine—Oedema—Epirubicin—liver cancer	0.0021	0.00213	CcSEcCtD
Famotidine—Anaphylactic shock—Epirubicin—liver cancer	0.0021	0.00213	CcSEcCtD
Famotidine—Loss of consciousness—Doxorubicin—liver cancer	0.00209	0.00212	CcSEcCtD
Famotidine—Infection—Epirubicin—liver cancer	0.00208	0.00212	CcSEcCtD
Famotidine—Cough—Doxorubicin—liver cancer	0.00207	0.00211	CcSEcCtD
Famotidine—Shock—Epirubicin—liver cancer	0.00206	0.0021	CcSEcCtD
Famotidine—Convulsion—Doxorubicin—liver cancer	0.00206	0.00209	CcSEcCtD
Famotidine—Thrombocytopenia—Epirubicin—liver cancer	0.00205	0.00209	CcSEcCtD
Famotidine—Arthralgia—Doxorubicin—liver cancer	0.00202	0.00206	CcSEcCtD
Famotidine—Chest pain—Doxorubicin—liver cancer	0.00202	0.00206	CcSEcCtD
Famotidine—Myalgia—Doxorubicin—liver cancer	0.00202	0.00206	CcSEcCtD
Famotidine—Anxiety—Doxorubicin—liver cancer	0.00202	0.00205	CcSEcCtD
Famotidine—Anorexia—Epirubicin—liver cancer	0.002	0.00203	CcSEcCtD
Famotidine—Dry mouth—Doxorubicin—liver cancer	0.00198	0.00201	CcSEcCtD
Famotidine—Confusional state—Doxorubicin—liver cancer	0.00196	0.00199	CcSEcCtD
Famotidine—Oedema—Doxorubicin—liver cancer	0.00194	0.00197	CcSEcCtD
Famotidine—Anaphylactic shock—Doxorubicin—liver cancer	0.00194	0.00197	CcSEcCtD
Famotidine—Infection—Doxorubicin—liver cancer	0.00193	0.00196	CcSEcCtD
Famotidine—Musculoskeletal discomfort—Epirubicin—liver cancer	0.00191	0.00194	CcSEcCtD
Famotidine—Shock—Doxorubicin—liver cancer	0.00191	0.00194	CcSEcCtD
Famotidine—Thrombocytopenia—Doxorubicin—liver cancer	0.0019	0.00193	CcSEcCtD
Famotidine—Insomnia—Epirubicin—liver cancer	0.0019	0.00193	CcSEcCtD
Famotidine—Paraesthesia—Epirubicin—liver cancer	0.00188	0.00191	CcSEcCtD
Famotidine—Somnolence—Epirubicin—liver cancer	0.00186	0.00189	CcSEcCtD
Famotidine—Anorexia—Doxorubicin—liver cancer	0.00185	0.00188	CcSEcCtD
Famotidine—Dyspepsia—Epirubicin—liver cancer	0.00185	0.00188	CcSEcCtD
Famotidine—Decreased appetite—Epirubicin—liver cancer	0.00182	0.00185	CcSEcCtD
Famotidine—Fatigue—Epirubicin—liver cancer	0.00181	0.00184	CcSEcCtD
Famotidine—Pain—Epirubicin—liver cancer	0.00179	0.00182	CcSEcCtD
Famotidine—Constipation—Epirubicin—liver cancer	0.00179	0.00182	CcSEcCtD
Famotidine—Musculoskeletal discomfort—Doxorubicin—liver cancer	0.00177	0.0018	CcSEcCtD
Famotidine—Insomnia—Doxorubicin—liver cancer	0.00175	0.00178	CcSEcCtD
Famotidine—Paraesthesia—Doxorubicin—liver cancer	0.00174	0.00177	CcSEcCtD
Famotidine—Feeling abnormal—Epirubicin—liver cancer	0.00173	0.00176	CcSEcCtD
Famotidine—Somnolence—Doxorubicin—liver cancer	0.00172	0.00175	CcSEcCtD
Famotidine—Gastrointestinal pain—Epirubicin—liver cancer	0.00171	0.00174	CcSEcCtD
Famotidine—Dyspepsia—Doxorubicin—liver cancer	0.00171	0.00174	CcSEcCtD
Famotidine—Decreased appetite—Doxorubicin—liver cancer	0.00169	0.00171	CcSEcCtD
Famotidine—Fatigue—Doxorubicin—liver cancer	0.00167	0.0017	CcSEcCtD
Famotidine—Urticaria—Epirubicin—liver cancer	0.00167	0.00169	CcSEcCtD
Famotidine—Pain—Doxorubicin—liver cancer	0.00166	0.00169	CcSEcCtD
Famotidine—Constipation—Doxorubicin—liver cancer	0.00166	0.00169	CcSEcCtD
Famotidine—Abdominal pain—Epirubicin—liver cancer	0.00166	0.00168	CcSEcCtD
Famotidine—Body temperature increased—Epirubicin—liver cancer	0.00166	0.00168	CcSEcCtD
Famotidine—Feeling abnormal—Doxorubicin—liver cancer	0.0016	0.00162	CcSEcCtD
Famotidine—Gastrointestinal pain—Doxorubicin—liver cancer	0.00159	0.00161	CcSEcCtD
Famotidine—Hypersensitivity—Epirubicin—liver cancer	0.00154	0.00157	CcSEcCtD
Famotidine—Urticaria—Doxorubicin—liver cancer	0.00154	0.00157	CcSEcCtD
Famotidine—Body temperature increased—Doxorubicin—liver cancer	0.00153	0.00156	CcSEcCtD
Famotidine—Abdominal pain—Doxorubicin—liver cancer	0.00153	0.00156	CcSEcCtD
Famotidine—Asthenia—Epirubicin—liver cancer	0.0015	0.00153	CcSEcCtD
Famotidine—Pruritus—Epirubicin—liver cancer	0.00148	0.00151	CcSEcCtD
Famotidine—Diarrhoea—Epirubicin—liver cancer	0.00143	0.00146	CcSEcCtD
Famotidine—Hypersensitivity—Doxorubicin—liver cancer	0.00143	0.00145	CcSEcCtD
Famotidine—Asthenia—Doxorubicin—liver cancer	0.00139	0.00141	CcSEcCtD
Famotidine—Dizziness—Epirubicin—liver cancer	0.00139	0.00141	CcSEcCtD
Famotidine—Pruritus—Doxorubicin—liver cancer	0.00137	0.00139	CcSEcCtD
Famotidine—Vomiting—Epirubicin—liver cancer	0.00133	0.00135	CcSEcCtD
Famotidine—Diarrhoea—Doxorubicin—liver cancer	0.00133	0.00135	CcSEcCtD
Famotidine—Rash—Epirubicin—liver cancer	0.00132	0.00134	CcSEcCtD
Famotidine—Dermatitis—Epirubicin—liver cancer	0.00132	0.00134	CcSEcCtD
Famotidine—Headache—Epirubicin—liver cancer	0.00131	0.00133	CcSEcCtD
Famotidine—Dizziness—Doxorubicin—liver cancer	0.00128	0.0013	CcSEcCtD
Famotidine—Nausea—Epirubicin—liver cancer	0.00125	0.00127	CcSEcCtD
Famotidine—Vomiting—Doxorubicin—liver cancer	0.00123	0.00125	CcSEcCtD
Famotidine—Rash—Doxorubicin—liver cancer	0.00122	0.00124	CcSEcCtD
Famotidine—Dermatitis—Doxorubicin—liver cancer	0.00122	0.00124	CcSEcCtD
Famotidine—Headache—Doxorubicin—liver cancer	0.00122	0.00124	CcSEcCtD
Famotidine—Nausea—Doxorubicin—liver cancer	0.00115	0.00117	CcSEcCtD
Famotidine—SLC47A1—SLC-mediated transmembrane transport—SLC40A1—liver cancer	0.000354	0.022	CbGpPWpGaD
Famotidine—CYP2C19—Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE)—CYP1A1—liver cancer	0.00034	0.0211	CbGpPWpGaD
Famotidine—CYP2C19—Constitutive Androstane Receptor Pathway—NR1I3—liver cancer	0.000309	0.0192	CbGpPWpGaD
Famotidine—CYP2C19—Constitutive Androstane Receptor Pathway—GSTA2—liver cancer	0.000276	0.0171	CbGpPWpGaD
Famotidine—SLC22A2—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC11A2—liver cancer	0.000268	0.0166	CbGpPWpGaD
Famotidine—SLC22A2—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC40A1—liver cancer	0.000255	0.0158	CbGpPWpGaD
Famotidine—CYP2C19—Xenobiotics—CYP2E1—liver cancer	0.00025	0.0155	CbGpPWpGaD
Famotidine—CYP2C19—Tamoxifen metabolism—CYP2E1—liver cancer	0.00024	0.0149	CbGpPWpGaD
Famotidine—CYP2C19—Cytochrome P450 - arranged by substrate type—NR1H4—liver cancer	0.00019	0.0118	CbGpPWpGaD
Famotidine—SLC47A1—Transmembrane transport of small molecules—SLC11A2—liver cancer	0.000189	0.0117	CbGpPWpGaD
Famotidine—SLC47A1—Transmembrane transport of small molecules—SLC40A1—liver cancer	0.00018	0.0112	CbGpPWpGaD
Famotidine—CYP2C19—Xenobiotics—CYP1A1—liver cancer	0.000179	0.0111	CbGpPWpGaD
Famotidine—SLC22A8—SLC-mediated transmembrane transport—SLC11A2—liver cancer	0.000175	0.0108	CbGpPWpGaD
Famotidine—SLC22A8—Transmembrane transport of small molecules—SLC9C1—liver cancer	0.000174	0.0108	CbGpPWpGaD
Famotidine—SLC22A8—Transmembrane transport of small molecules—MYO5B—liver cancer	0.000174	0.0108	CbGpPWpGaD
Famotidine—CYP2C19—Tamoxifen metabolism—CYP1A1—liver cancer	0.000173	0.0107	CbGpPWpGaD
Famotidine—SLC47A1—Transmembrane transport of small molecules—ATP7B—liver cancer	0.000172	0.0107	CbGpPWpGaD
Famotidine—SLC47A1—Transmembrane transport of small molecules—ANXA2—liver cancer	0.000172	0.0107	CbGpPWpGaD
Famotidine—SLC22A8—SLC-mediated transmembrane transport—SLC40A1—liver cancer	0.000167	0.0103	CbGpPWpGaD
Famotidine—SLC47A1—Transmembrane transport of small molecules—NR1H4—liver cancer	0.000163	0.0101	CbGpPWpGaD
Famotidine—CYP2C19—Phase 1 - Functionalization of compounds—NR1H4—liver cancer	0.000154	0.00957	CbGpPWpGaD
Famotidine—HRH2—GPCRs, Class A Rhodopsin-like—CCR4—liver cancer	0.00015	0.00932	CbGpPWpGaD
Famotidine—CYP2C19—Arachidonic acid metabolism—HPGDS—liver cancer	0.000147	0.00913	CbGpPWpGaD
Famotidine—CYP2C19—Biological oxidations—UGDH—liver cancer	0.00014	0.0087	CbGpPWpGaD
Famotidine—SLC22A2—Transmission across Chemical Synapses—GLUL—liver cancer	0.000135	0.00835	CbGpPWpGaD
Famotidine—CYP2C19—Melatonin metabolism and effects—CYP1A1—liver cancer	0.000133	0.00827	CbGpPWpGaD
Famotidine—HRH2—Class A/1 (Rhodopsin-like receptors)—CCR4—liver cancer	0.000129	0.00798	CbGpPWpGaD
Famotidine—SLC22A2—SLC-mediated transmembrane transport—SLC11A2—liver cancer	0.000122	0.00755	CbGpPWpGaD
Famotidine—SLC22A2—Transmembrane transport of small molecules—MYO5B—liver cancer	0.000121	0.00749	CbGpPWpGaD
Famotidine—SLC22A2—Transmembrane transport of small molecules—SLC9C1—liver cancer	0.000121	0.00749	CbGpPWpGaD
Famotidine—SLC22A2—SLC-mediated transmembrane transport—SLC40A1—liver cancer	0.000116	0.0072	CbGpPWpGaD
Famotidine—CYP2C19—Arachidonic acid metabolism—GGT1—liver cancer	0.00011	0.00683	CbGpPWpGaD
Famotidine—CYP2C19—Cytochrome P450 - arranged by substrate type—CYP2E1—liver cancer	0.000104	0.00643	CbGpPWpGaD
Famotidine—SLC22A2—Neuronal System—GLUL—liver cancer	0.000103	0.0064	CbGpPWpGaD
Famotidine—CYP2C19—Oxidation by Cytochrome P450—CYP2E1—liver cancer	0.000102	0.00635	CbGpPWpGaD
Famotidine—HRH2—GPCR ligand binding—CCR4—liver cancer	9.8e-05	0.00608	CbGpPWpGaD
Famotidine—SLC22A8—Transmembrane transport of small molecules—SLC11A2—liver cancer	8.88e-05	0.00551	CbGpPWpGaD
Famotidine—CYP2C19—Arachidonic acid metabolism—CYP1A1—liver cancer	8.62e-05	0.00535	CbGpPWpGaD
Famotidine—SLC47A1—SLC-mediated transmembrane transport—ALB—liver cancer	8.54e-05	0.0053	CbGpPWpGaD
Famotidine—SLC22A8—Transmembrane transport of small molecules—SLC40A1—liver cancer	8.47e-05	0.00526	CbGpPWpGaD
Famotidine—CYP2C19—Phase 1 - Functionalization of compounds—CYP2E1—liver cancer	8.4e-05	0.00521	CbGpPWpGaD
Famotidine—SLC47A1—Transmembrane transport of small molecules—CYCS—liver cancer	8.31e-05	0.00516	CbGpPWpGaD
Famotidine—CYP2C19—Biological oxidations—NR1H4—liver cancer	8.2e-05	0.00508	CbGpPWpGaD
Famotidine—SLC22A8—Transmembrane transport of small molecules—ANXA2—liver cancer	8.13e-05	0.00504	CbGpPWpGaD
Famotidine—SLC22A8—Transmembrane transport of small molecules—ATP7B—liver cancer	8.13e-05	0.00504	CbGpPWpGaD
Famotidine—CYP2C19—Biological oxidations—GSTA3—liver cancer	8.06e-05	0.005	CbGpPWpGaD
Famotidine—CYP2C19—Metapathway biotransformation—GSTA3—liver cancer	7.95e-05	0.00493	CbGpPWpGaD
Famotidine—SLC22A8—Transmembrane transport of small molecules—NR1H4—liver cancer	7.68e-05	0.00477	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—CHN2—liver cancer	7.46e-05	0.00463	CbGpPWpGaD
Famotidine—CYP2C19—Cytochrome P450 - arranged by substrate type—CYP1A1—liver cancer	7.45e-05	0.00462	CbGpPWpGaD
Famotidine—CYP2C19—Biological oxidations—GSTA4—liver cancer	7.37e-05	0.00457	CbGpPWpGaD
Famotidine—CYP2C19—Oxidation by Cytochrome P450—CYP1A1—liver cancer	7.35e-05	0.00456	CbGpPWpGaD
Famotidine—CYP2C19—Metapathway biotransformation—GSTA4—liver cancer	7.27e-05	0.00451	CbGpPWpGaD
Famotidine—SLC47A1—Transmembrane transport of small molecules—HMOX1—liver cancer	7.23e-05	0.00448	CbGpPWpGaD
Famotidine—CYP2C19—Biological oxidations—GSTA2—liver cancer	7.18e-05	0.00445	CbGpPWpGaD
Famotidine—CYP2C19—Biological oxidations—GSTA1—liver cancer	6.93e-05	0.0043	CbGpPWpGaD
Famotidine—CYP2C19—Biological oxidations—NAT2—liver cancer	6.85e-05	0.00425	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—IFT88—liver cancer	6.83e-05	0.00423	CbGpPWpGaD
Famotidine—CYP2C19—Metapathway biotransformation—NAT2—liver cancer	6.76e-05	0.00419	CbGpPWpGaD
Famotidine—SLC22A2—Transmembrane transport of small molecules—SLC11A2—liver cancer	6.18e-05	0.00383	CbGpPWpGaD
Famotidine—CYP2C19—Phase 1 - Functionalization of compounds—CYP1A1—liver cancer	6.04e-05	0.00375	CbGpPWpGaD
Famotidine—SLC22A2—Transmembrane transport of small molecules—SLC40A1—liver cancer	5.9e-05	0.00366	CbGpPWpGaD
Famotidine—SLC47A1—Transmembrane transport of small molecules—PPARA—liver cancer	5.84e-05	0.00362	CbGpPWpGaD
Famotidine—HRH2—GPCR downstream signaling—TRIO—liver cancer	5.78e-05	0.00358	CbGpPWpGaD
Famotidine—CYP2C19—Metapathway biotransformation—GPX3—liver cancer	5.74e-05	0.00356	CbGpPWpGaD
Famotidine—SLC22A2—Transmembrane transport of small molecules—ANXA2—liver cancer	5.65e-05	0.00351	CbGpPWpGaD
Famotidine—SLC22A2—Transmembrane transport of small molecules—ATP7B—liver cancer	5.65e-05	0.00351	CbGpPWpGaD
Famotidine—HRH2—GPCR downstream signaling—CCR4—liver cancer	5.54e-05	0.00344	CbGpPWpGaD
Famotidine—CYP2C19—Biological oxidations—HPGDS—liver cancer	5.48e-05	0.0034	CbGpPWpGaD
Famotidine—SLC22A2—Transmembrane transport of small molecules—NR1H4—liver cancer	5.35e-05	0.00332	CbGpPWpGaD
Famotidine—HRH2—Signaling by GPCR—TRIO—liver cancer	5.25e-05	0.00325	CbGpPWpGaD
Famotidine—HRH2—Class A/1 (Rhodopsin-like receptors)—F2—liver cancer	5.14e-05	0.00319	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism of lipids and lipoproteins—EPT1—liver cancer	5.06e-05	0.00314	CbGpPWpGaD
Famotidine—HRH2—Signaling by GPCR—CCR4—liver cancer	5.03e-05	0.00312	CbGpPWpGaD
Famotidine—CYP2C19—Biological oxidations—CYP2E1—liver cancer	4.46e-05	0.00277	CbGpPWpGaD
Famotidine—CYP2C19—Metapathway biotransformation—CYP2E1—liver cancer	4.4e-05	0.00273	CbGpPWpGaD
Famotidine—SLC47A1—Transmembrane transport of small molecules—ALB—liver cancer	4.34e-05	0.00269	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—UGDH—liver cancer	4.29e-05	0.00266	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—SHC3—liver cancer	4.18e-05	0.0026	CbGpPWpGaD
Famotidine—CYP2C19—Biological oxidations—GGT1—liver cancer	4.1e-05	0.00254	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—EPT1—liver cancer	4.03e-05	0.0025	CbGpPWpGaD
Famotidine—SLC22A8—SLC-mediated transmembrane transport—ALB—liver cancer	4.02e-05	0.0025	CbGpPWpGaD
Famotidine—SLC47A1—Transmembrane transport of small molecules—RAF1—liver cancer	3.92e-05	0.00243	CbGpPWpGaD
Famotidine—HRH2—GPCR ligand binding—F2—liver cancer	3.92e-05	0.00243	CbGpPWpGaD
Famotidine—SLC22A8—Transmembrane transport of small molecules—CYCS—liver cancer	3.92e-05	0.00243	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—TAT—liver cancer	3.82e-05	0.00237	CbGpPWpGaD
Famotidine—SLC22A2—Transmission across Chemical Synapses—BRAF—liver cancer	3.74e-05	0.00232	CbGpPWpGaD
Famotidine—CYP2C19—Biological oxidations—GSTP1—liver cancer	3.68e-05	0.00228	CbGpPWpGaD
Famotidine—CYP2C19—Metapathway biotransformation—GSTP1—liver cancer	3.63e-05	0.00225	CbGpPWpGaD
Famotidine—SLC22A8—Transmembrane transport of small molecules—HMOX1—liver cancer	3.4e-05	0.00211	CbGpPWpGaD
Famotidine—CYP2C19—Biological oxidations—GSTM1—liver cancer	3.38e-05	0.0021	CbGpPWpGaD
Famotidine—CYP2C19—Metapathway biotransformation—GSTM1—liver cancer	3.34e-05	0.00207	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism of lipids and lipoproteins—CPT1B—liver cancer	3.26e-05	0.00202	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—FST—liver cancer	3.25e-05	0.00202	CbGpPWpGaD
Famotidine—CYP2C19—Biological oxidations—CYP1A1—liver cancer	3.21e-05	0.00199	CbGpPWpGaD
Famotidine—HRH2—GPCR downstream signaling—PRKCE—liver cancer	3.19e-05	0.00198	CbGpPWpGaD
Famotidine—CYP2C19—Metapathway biotransformation—CYP1A1—liver cancer	3.16e-05	0.00196	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism of lipids and lipoproteins—NR1H4—liver cancer	3.15e-05	0.00195	CbGpPWpGaD
Famotidine—SLC22A2—Transmission across Chemical Synapses—RAF1—liver cancer	3.12e-05	0.00194	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—TRIO—liver cancer	3.1e-05	0.00192	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—CCR4—liver cancer	2.97e-05	0.00184	CbGpPWpGaD
Famotidine—HRH2—Signaling by GPCR—PRKCE—liver cancer	2.9e-05	0.0018	CbGpPWpGaD
Famotidine—SLC22A2—Neuronal System—BRAF—liver cancer	2.87e-05	0.00178	CbGpPWpGaD
Famotidine—HRH2—GPCR downstream signaling—CSF2—liver cancer	2.82e-05	0.00175	CbGpPWpGaD
Famotidine—SLC22A2—SLC-mediated transmembrane transport—ALB—liver cancer	2.8e-05	0.00174	CbGpPWpGaD
Famotidine—SLC22A8—Transmembrane transport of small molecules—PPARA—liver cancer	2.75e-05	0.00171	CbGpPWpGaD
Famotidine—SLC22A2—Transmembrane transport of small molecules—CYCS—liver cancer	2.72e-05	0.00169	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—CPT1B—liver cancer	2.6e-05	0.00161	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—GLUL—liver cancer	2.6e-05	0.00161	CbGpPWpGaD
Famotidine—HRH2—Signaling by GPCR—CSF2—liver cancer	2.56e-05	0.00159	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—NR1H4—liver cancer	2.5e-05	0.00155	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—GSTA3—liver cancer	2.46e-05	0.00153	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism of lipids and lipoproteins—CRABP1—liver cancer	2.41e-05	0.00149	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—UGDH—liver cancer	2.4e-05	0.00149	CbGpPWpGaD
Famotidine—SLC22A2—Neuronal System—RAF1—liver cancer	2.39e-05	0.00148	CbGpPWpGaD
Famotidine—SLC22A2—Transmembrane transport of small molecules—HMOX1—liver cancer	2.37e-05	0.00147	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—ADAM17—liver cancer	2.35e-05	0.00146	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—EPT1—liver cancer	2.26e-05	0.0014	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—GSTA4—liver cancer	2.25e-05	0.0014	CbGpPWpGaD
Famotidine—HRH2—GPCR downstream signaling—F2—liver cancer	2.21e-05	0.00137	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—PSMA4—liver cancer	2.21e-05	0.00137	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—PSMD10—liver cancer	2.21e-05	0.00137	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—GSTA2—liver cancer	2.19e-05	0.00136	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—TAT—liver cancer	2.14e-05	0.00133	CbGpPWpGaD
Famotidine—HRH2—GPCR downstream signaling—PIK3CG—liver cancer	2.12e-05	0.00131	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—GSTA1—liver cancer	2.12e-05	0.00131	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism of lipids and lipoproteins—HPGDS—liver cancer	2.1e-05	0.0013	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—NAT2—liver cancer	2.09e-05	0.0013	CbGpPWpGaD
Famotidine—SLC22A8—Transmembrane transport of small molecules—ALB—liver cancer	2.04e-05	0.00127	CbGpPWpGaD
Famotidine—HRH2—Signaling by GPCR—F2—liver cancer	2.01e-05	0.00125	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—ALDOB—liver cancer	2.01e-05	0.00124	CbGpPWpGaD
Famotidine—HRH2—Signaling by GPCR—PIK3CG—liver cancer	1.92e-05	0.00119	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—CRABP1—liver cancer	1.91e-05	0.00119	CbGpPWpGaD
Famotidine—SLC22A2—Transmembrane transport of small molecules—PPARA—liver cancer	1.91e-05	0.00119	CbGpPWpGaD
Famotidine—HRH2—GPCR downstream signaling—PIK3CD—liver cancer	1.86e-05	0.00116	CbGpPWpGaD
Famotidine—SLC22A8—Transmembrane transport of small molecules—RAF1—liver cancer	1.85e-05	0.00115	CbGpPWpGaD
Famotidine—SLC22A2—Transmission across Chemical Synapses—HRAS—liver cancer	1.72e-05	0.00107	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—PRKCE—liver cancer	1.71e-05	0.00106	CbGpPWpGaD
Famotidine—HRH2—Signaling by GPCR—PIK3CD—liver cancer	1.69e-05	0.00105	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—HPGDS—liver cancer	1.67e-05	0.00104	CbGpPWpGaD
Famotidine—HRH2—GPCR downstream signaling—PIK3CB—liver cancer	1.62e-05	0.00101	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—IGF2—liver cancer	1.62e-05	0.00101	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism of lipids and lipoproteins—GGT1—liver cancer	1.57e-05	0.000976	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—CSF2—liver cancer	1.51e-05	0.000939	CbGpPWpGaD
Famotidine—HRH2—Signaling by GPCR—RAF1—liver cancer	1.51e-05	0.000937	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—H2AFX—liver cancer	1.49e-05	0.000925	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—PSMA4—liver cancer	1.49e-05	0.000925	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—PSMD10—liver cancer	1.49e-05	0.000925	CbGpPWpGaD
Famotidine—HRH2—GPCR downstream signaling—IL2—liver cancer	1.49e-05	0.000925	CbGpPWpGaD
Famotidine—HRH2—Signaling by GPCR—PIK3CB—liver cancer	1.47e-05	0.000914	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—CPT1B—liver cancer	1.45e-05	0.000902	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—GLUL—liver cancer	1.45e-05	0.000902	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—GOT2—liver cancer	1.45e-05	0.0009	CbGpPWpGaD
Famotidine—SLC22A2—Transmembrane transport of small molecules—ALB—liver cancer	1.42e-05	0.000882	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—NR1H4—liver cancer	1.4e-05	0.000869	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—GSTA3—liver cancer	1.38e-05	0.000855	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—CYP2E1—liver cancer	1.36e-05	0.000846	CbGpPWpGaD
Famotidine—HRH2—Signaling by GPCR—IL2—liver cancer	1.35e-05	0.00084	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—TERT—liver cancer	1.35e-05	0.000837	CbGpPWpGaD
Famotidine—SLC22A2—Neuronal System—HRAS—liver cancer	1.32e-05	0.000817	CbGpPWpGaD
Famotidine—SLC22A2—Transmembrane transport of small molecules—RAF1—liver cancer	1.29e-05	0.000798	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—CYCS—liver cancer	1.28e-05	0.000792	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—GSTA4—liver cancer	1.26e-05	0.000782	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—GGT1—liver cancer	1.25e-05	0.000777	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—GOT1—liver cancer	1.25e-05	0.000777	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—KDR—liver cancer	1.23e-05	0.000765	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism of lipids and lipoproteins—CYP1A1—liver cancer	1.23e-05	0.000764	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—GSTA2—liver cancer	1.23e-05	0.000762	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—MAPK14—liver cancer	1.23e-05	0.00076	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—ESR1—liver cancer	1.2e-05	0.000746	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—F2—liver cancer	1.19e-05	0.000737	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—GSTA1—liver cancer	1.18e-05	0.000735	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—NAT2—liver cancer	1.17e-05	0.000727	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—APC—liver cancer	1.14e-05	0.000705	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—PIK3CG—liver cancer	1.14e-05	0.000705	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism of lipids and lipoproteins—PPARA—liver cancer	1.13e-05	0.000699	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—GSTP1—liver cancer	1.12e-05	0.000698	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—ALDOB—liver cancer	1.12e-05	0.000697	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—HMOX1—liver cancer	1.11e-05	0.000688	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—CRABP1—liver cancer	1.07e-05	0.000665	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—BRAF—liver cancer	1.07e-05	0.000663	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—GSTM1—liver cancer	1.03e-05	0.000641	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—PIK3CD—liver cancer	9.99e-06	0.00062	CbGpPWpGaD
Famotidine—HRH2—GPCR downstream signaling—PIK3CA—liver cancer	9.9e-06	0.000614	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—SERPINE1—liver cancer	9.88e-06	0.000613	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—CYP1A1—liver cancer	9.8e-06	0.000608	CbGpPWpGaD
Famotidine—HRH2—Signaling by GPCR—KRAS—liver cancer	9.78e-06	0.000607	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CG—liver cancer	9.65e-06	0.000599	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—HPGDS—liver cancer	9.37e-06	0.000581	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—liver cancer	9.31e-06	0.000578	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—MTHFR—liver cancer	9.14e-06	0.000567	CbGpPWpGaD
Famotidine—HRH2—Signaling by GPCR—PIK3CA—liver cancer	8.99e-06	0.000557	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—PPARA—liver cancer	8.96e-06	0.000556	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—RAF1—liver cancer	8.92e-06	0.000553	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—MTOR—liver cancer	8.71e-06	0.00054	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—PIK3CB—liver cancer	8.71e-06	0.00054	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CD—liver cancer	8.48e-06	0.000526	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism of lipids and lipoproteins—ALB—liver cancer	8.37e-06	0.000519	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—PSMA4—liver cancer	8.35e-06	0.000518	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—PSMD10—liver cancer	8.35e-06	0.000518	CbGpPWpGaD
Famotidine—HRH2—Signaling by GPCR—HRAS—liver cancer	8.31e-06	0.000516	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—CDKN1B—liver cancer	8.17e-06	0.000507	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—GOT2—liver cancer	8.12e-06	0.000504	CbGpPWpGaD
Famotidine—HRH2—GPCR downstream signaling—AKT1—liver cancer	8.08e-06	0.000502	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—CASP3—liver cancer	8.01e-06	0.000497	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—IL2—liver cancer	8e-06	0.000496	CbGpPWpGaD
Famotidine—HRH2—Signaling by GPCR—IL6—liver cancer	7.96e-06	0.000494	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—CCND1—liver cancer	7.8e-06	0.000484	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—JUN—liver cancer	7.78e-06	0.000483	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—CTNNB1—liver cancer	7.72e-06	0.000479	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—PIK3CG—liver cancer	7.68e-06	0.000476	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—CYP2E1—liver cancer	7.63e-06	0.000474	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—MMP9—liver cancer	7.57e-06	0.00047	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—CDKN1A—liver cancer	7.54e-06	0.000468	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—PPARG—liver cancer	7.41e-06	0.00046	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CB—liver cancer	7.39e-06	0.000459	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—MAPK8—liver cancer	7.36e-06	0.000457	CbGpPWpGaD
Famotidine—HRH2—Signaling by GPCR—AKT1—liver cancer	7.34e-06	0.000455	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—CYCS—liver cancer	7.14e-06	0.000443	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—GOT1—liver cancer	7.01e-06	0.000435	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—GGT1—liver cancer	7.01e-06	0.000435	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—VEGFA—liver cancer	6.8e-06	0.000422	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—PIK3CD—liver cancer	6.75e-06	0.000419	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—STAT3—liver cancer	6.73e-06	0.000417	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—ALB—liver cancer	6.66e-06	0.000413	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—GSTP1—liver cancer	6.3e-06	0.000391	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—MYC—liver cancer	6.25e-06	0.000388	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—TGFB1—liver cancer	6.24e-06	0.000387	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—HMOX1—liver cancer	6.21e-06	0.000385	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—PIK3CB—liver cancer	5.88e-06	0.000365	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—GSTM1—liver cancer	5.79e-06	0.000359	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—KRAS—liver cancer	5.78e-06	0.000358	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—CYP1A1—liver cancer	5.49e-06	0.00034	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—PIK3CA—liver cancer	5.31e-06	0.000329	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—TP53—liver cancer	5.14e-06	0.000319	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—MTHFR—liver cancer	5.11e-06	0.000317	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—PPARA—liver cancer	5.02e-06	0.000311	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—HRAS—liver cancer	4.91e-06	0.000305	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—IL6—liver cancer	4.7e-06	0.000292	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—liver cancer	4.51e-06	0.00028	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—AKT1—liver cancer	4.34e-06	0.000269	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—PIK3CG—liver cancer	4.3e-06	0.000267	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—PPARG—liver cancer	4.15e-06	0.000257	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—PIK3CD—liver cancer	3.78e-06	0.000234	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—ALB—liver cancer	3.73e-06	0.000231	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—PIK3CA—liver cancer	3.59e-06	0.000222	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—PIK3CB—liver cancer	3.29e-06	0.000204	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—AKT1—liver cancer	2.93e-06	0.000182	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—PIK3CA—liver cancer	2.01e-06	0.000125	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—AKT1—liver cancer	1.64e-06	0.000102	CbGpPWpGaD
